State Ledger
Company profile

ROCKET PHARMACEUTICALS, INC. CIK 1281895

Ticker
RCKT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10118
Fiscal year end
2025 (FY)
Market Data
Close
$2.49
Change
-$0.08
Change %
-3.11%
Volume
146,525

RCKT · trading date Oct 12, 2026 · previous close $2.57 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$223.12M
Total assets
$330.45M
Total liabilities
$53.23M
Stockholders' equity
$277.22M
Cash & equivalents
$77.56M
Operating income
-$231.75M
Operating cash flow
-$190.01M
Capital expenditures
$440.0K

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$190.45M
Free cash flow margin
—
Liabilities / assets
16.1%
Equity / assets
83.9%
CapEx / revenue
—
Operating cash flow / net income
0.85×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$223.12M $330.45M $53.23M $277.22M
2024 $0 -$258.75M $527.70M $64.47M $463.23M
2023 $0 -$245.60M $566.34M $73.77M $492.57M
2022 $0 -$221.86M $551.81M $62.12M $489.69M
2021 $0 -$169.07M $497.02M $42.30M $454.72M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-15
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10118
350 FIFTH AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies